rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Chemed Corp

CHE · NYSE

Health CareProviders & FacilitiesLeading

CHE stood above a rising 150-day average in 17 of the last 52 weekly readings, including each of the last 17 weeks. It is 11.1% above that average now. Providers & Facilities: 51% of its 53 stocks in an uptrend (+8 points in four weeks); Health Care: 28% (−6 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
17 in a row
Industry in uptrend
51% +8 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$16.6M
Officials’ trades on record
10
Institutions holding
486 (+37)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 17 of 52 weeks.

23 Apr – 22 Oct
28%44%59%Apr 26Jun 26Jul 26Sep 26Oct 26

Providers & Facilities: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$5.2M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

10 disclosed lines: House 8, Senate 2, executive 0; 6 people.

WhoDidAmountTraded
Lisa C. McClain House: U.S. House ClerkMI09boughtspouse$1k–$15k24 Jun 2025filed 13 Aug 2025
Byron Donalds House: U.S. House ClerkFL19soldspouse$1k–$15k6 Mar 2025filed 14 Apr 2025
Byron Donalds House: U.S. House ClerkFL19sold$1k–$15k6 Mar 2025filed 14 Apr 2025
Daniel S. Goldman House: U.S. House ClerkNY10sold$1k–$15k31 Jan 2023filed 24 Feb 2023
Tommy Tuberville Senate: U.S. Senate eFDSenatorsoldjoint$1k–$15k29 Sep 2021filed 15 Oct 2021
Byron Donalds House: U.S. House ClerkFL19boughtspouse$1k–$15k5 May 2021filed 8 Nov 2024
Tommy Tuberville Senate: U.S. Senate eFDSenatorboughtjoint$1k–$15k29 Mar 2021filed 23 Jul 2021
Greg Gianforte House: U.S. House ClerkMT00sold$1k–$15k13 Oct 2020filed 9 Nov 2020
Donna E. Shalala House: U.S. House ClerkFL27sold$1k–$15k24 Jun 2019filed 27 Apr 2020
Greg Gianforte House: U.S. House ClerkMT00sold$50k–$100k17 Jul 2017filed 7 Aug 2017

Insiders

Buy orders, 12 months0
Sale orders, 12 months13
Buyers · sellers0 · 5
WhoDidSharesTraded
Kevin J. McNamarapresident and CEOsold2,000at $513.4528 Sep 2026filed 30 Sep 2026
Kevin J. McNamarapresident and CEOsold2,000at $501.4018 Sep 2026filed 21 Sep 2026
Kevin J. McNamarapresident and CEOsold2,000at $541.1621 Aug 2026filed 24 Aug 2026
Spencer S. Leeexecutive vice presidentsold1,000at $541.0421 Aug 2026filed 24 Aug 2026
Kevin J. McNamarapresident and CEOsold2,000at $539.513 Aug 2026filed 4 Aug 2026
Patrick P. GraceDirectorsold190at $532.0031 Jul 2026filed 3 Aug 2026
Andrea R. LindellDirectorsold1,347at $447.339 Jun 2026filed 10 Jun 2026
George J. Walsh IIIDirectorsold500at $437.8329 May 2026filed 29 May 2026
Patrick P. GraceDirectorsold60at $425.788 May 2026filed 8 May 2026
Kevin J. McNamarapresident and CEOsold2,000at $421.131 May 2026filed 4 May 2026
Kevin J. McNamarapresident and CEOsold1,500at $369.3727 Mar 2026filed 30 Mar 2026
Kevin J. McNamarapresident and CEOsold2,000at $403.1812 Mar 2026filed 13 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders486+37 on the quarter
New · exited101 · 63
Reported value$5.9B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20261,484,282$691.3M+147,592+11.0%
AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 2026972,474$446.2M+556,862+134.0%
VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 2026787,068$366.6M-28,631−3.5%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026604,420$281.5M-31,650−5.0%
STATE STREET CORPreduced · filed 7 Aug 2026444,716$207.1M-17,454−3.8%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026413,942$192.8M+2,896+0.7%
JPMORGAN CHASE & COnew · filed 12 Aug 2026403,395$185.8M+403,395
Boston Partnersnew · filed 4 Aug 2026280,684$130.7M+280,684
Epoch Investment Partners, Inc.added · filed 13 Aug 2026267,290$124.5M+17,167+6.9%
DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 2026260,561$121.3M+12,711+5.1%
31 Mar 2023 – 30 Jun 2026
371433495Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Brian C. Judkins Company insiderVP and Chief Legal Officer · last 20 Oct 20262 · 2
Joel L. Wherley Company insiderCEO - Vitas Healthcare · last 20 Oct 20260 · 0
Kevin J. McNamara Company insiderpresident and CEO · last 20 Oct 20260 · 109
Michael D. Witzeman Company insiderVP & Chief Financial Officer · last 20 Oct 20260 · 14
Spencer S. Lee Company insiderexecutive vice president · last 20 Oct 20260 · 66
Thomas C. Hutton Company insidervice president · last 20 Oct 20260 · 14
Patrick P. Grace Company insiderDirector · last 31 Jul 20262 · 27
Andrea R. Lindell Company insiderDirector · last 9 Jun 20260 · 3
George J. Walsh III Company insiderDirector · last 29 May 202635 · 8
Christopher J. Heaney Company insiderDirector · last 18 May 20260 · 0
Eileen P. McCarthy Company insiderDirector · last 18 May 20260 · 0
John Meredith Mount Jr. Company insiderDirector · last 18 May 20260 · 0

Same industry

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202532.5%
Operating profit marginFY 2025 · to 31 Dec 202513.4%
Free cash flow marginFY 2025 · to 31 Dec 202512.9%
Return on capital employedFY 2025 · to 31 Dec 202527.0%
Cash conversionFY 2025 · to 31 Dec 2025146%
Interest coverFY 2025 · to 31 Dec 2025193.28×
Share count trendFY 2025 · to 10 Feb 2026-4.8%
Cash and equivalentsFY 2025 · to 31 Dec 2025$74.5M
Free cash flowFY 2025 · to 31 Dec 2025$325.5M

Analyst forecasts

No analyst forecasts yet.